A first study of nonmethane hydrocarbons (NMHCs) on hazy and normal days was performed in Foshan for providing deep insight into the local deteriorating air quality. Ethane, propane, i-pentane, ethene, propene, ethyne, benzene, and toluene were eight most abundant compounds, accounting for 71%-85% of total NMHCs. Most hydrocarbons showed much higher levels on hazy days than normal days together with hydrocarbon/ethyne ratios and diurnal variations, indicating hazy days are more dominated by vehicular emission. Correlation coefficients (R(2)) of ethane, propane, ethane, propene, benzene, and total NMHCs with ethyne were 0.62-0.83, indicating these compounds are mainly related to vehicular emission. R(2) analysis indicated that solvent usage is responsible for toluene and other aromatic hydrocarbons (e.g., ethylbezene). Benzene/toluene (B/T) ratio was 0.44±0.23 during whole sampling periods, again indicating vehicular emission is the dominant source. Lower B/T ratio (0.30±0.14) on hazy days than that (0.58±0.21) on normal days suggested that solvent usage emitted toluene.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313607PMC
http://dx.doi.org/10.1089/ees.2010.0421DOI Listing

Publication Analysis

Top Keywords

normal days
16
hazy days
12
vehicular emission
12
nonmethane hydrocarbons
8
hazy normal
8
ethane propane
8
total nmhcs
8
solvent usage
8
b/t ratio
8
days
7

Similar Publications

Background: Marathon training and running have many beneficial effects on human health and physical fitness; however, they also pose risks. To date, no comprehensive review regarding both the benefits and risks of marathon running on different organ systems has been published.

Main Body: The aim of this review was to provide a comprehensive review of the benefits and risks of marathon training and racing on different organ systems.

View Article and Find Full Text PDF

Background: Multiple Sulfatase Deficiency (MSD) is a rare inherited lysosomal storage disorder characterized by loss of function mutations in the SUMF1 gene that manifests as a severe pediatric neurological disease. There are no available targeted therapies for MSD.

Methods: We engineered a viral vector (AAV9/SUMF1) to deliver working copies of the SUMF1 gene and tested the vector in Sumf1 knock out mice that generally display a median lifespan of 10 days.

View Article and Find Full Text PDF

Original article: Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-center, randomized, double-blind, placebo-controlled phase 2 clinical trial.

Clin Microbiol Infect

January 2025

National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; New Cornerstone Science Laboratory; National Clinical Research Center for Respiratory Diseases; Department of Respiratory Medicine, Capital Medical University, Institute of Respiratory Medicine of Capital Medical University; Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China. Electronic address:

Objectives: To evaluate the therapeutic effect of suraxavir marboxil (GP681, abbreviated as suraxavir) in adults with uncomplicated influenza.

Methods: We conducted a multi-center randomized, double-blind, placebo-controlled phase 2 trial in 18 Chinese centers. Participants had to be aged 18-65 years with positive influenza test, presenting with at least one influenza systemic and respiratory symptoms in at least moderate severity within 48 hours of onset.

View Article and Find Full Text PDF

Background: Preeclampsia is a major hypertensive disorder of pregnancy, which may lead to severe complications, particularly in the first two weeks of the postpartum period. During the postpartum period, blood pressure levels remain high, often increasing to levels higher than those experienced during pregnancy. Furosemide, a fast-acting diuretic, reduces the intravascular volume overload and may represent an alternative to accelerate the normalization of blood pressure levels.

View Article and Find Full Text PDF

Introduction: Niacin is a non-statin lipid-lowering therapy that has been shown to lower triglycerides and improve other risk factors for renal outcomes. Despite these favorable data, the effect of niacin on long-term kidney outcomes remains unclear. The aim of this study is to examine the associations of niacin therapies with incident chronic kidney disease (CKD), end-stage renal disease (ESRD), and death in patients with estimated glomerular filtration (eGFR) of at least 60 mL/min/1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!